aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib is a approved stage product being developed by Johnson & Johnson for Analgesics. The current trial status is completed. This product is registered under clinical trial identifier NCT00261586. Target conditions include Analgesics.
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00261586 | Approved | Completed |